|
MechanismSGLT1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with AKROS AG
0 Patents (Medical) associated with AKROS AG
100 Deals associated with AKROS AG
100 Translational Medicine associated with AKROS AG